Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dupont Jakob
Bolt Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Dupont Jakob
Bolt Biotherapeutics | 8-K: Current report
Bolt Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Bolt Biotherapeutics | 8-K: Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yonehiro Grant
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Quinn William P.
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nemec Sarah
Bolt Biotherapeutics | 8-K: Current report
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director SHAH MAHENDRA
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director ONETTO NICOLE
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director O'CALLAGHAN BRIAN
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Frank D.
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berner Laura
Bolt Biotherapeutics | 8-K: Current report
Bolt Biotherapeutics | DEFA14A: Others
Bolt Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Nemec Sarah
Bolt Biotherapeutics | 10-Q: Q1 2024 Earnings Report
No Data
No Data